CYTK - Cytokinetics, Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$109.91
DETAILS
HIGH:
$140.00
LOW:
$84.00
MEDIAN:
$112.00
CONSENSUS:
$109.91
UPSIDE:
48.72%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: CYTK has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.